Reduction of gangliosides, phospholipids and cholesterol content in cerebral cortex of rats caused by chronic hypermethioninemia

International Journal of Developmental Neuroscience

Volumn 25, Issue 7, 2007, Pages 473-477

  Stefanello, Francieli M ^a   Kreutz, Fernando ^a   Scherer, Emilene B S ^a   Breier, Ana C ^a   Vianna, Luciene P ^a   Trindade, Vera M T ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cerebral cortex; Cholesterol; Gangliosides; Hypermethioninemia; Phospholipids

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHOLESTEROL; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B; METHIONINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SPHINGOMYELIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHRONIC HYPERMETHIONINEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; LIPID COMPOSITION; LIPID PEROXIDATION; METABOLIC DISORDER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL CORTEX; CHOLESTEROL; CHROMATOGRAPHY, THIN LAYER; FEMALE; GANGLIOSIDES; INDICATORS AND REAGENTS; LIPID METABOLISM; LIPID PEROXIDATION; METHIONINE; PHOSPHOLIPIDS; PREGNANCY; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYNAPTIC MEMBRANES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 36048954220     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.08.004     Document Type: Article

References (60)

1. Agranoff B.W., and Hajra A.H. Lipids. In: Siegel G.J., Agranoff B.W., Albers R.W., and Molinoff P.B. (Eds). Basic Neurochemistry (1994), Raven Press, New York 97-116
2. Ando S. Gangliosides in the nervous system. Neurochem. Int. 5 (1983) 507-537
3. Augoustides-Savvopoulou P., Luka Z., Karyda S., Stabler S.P., Allen R.H., Patsiaoura K., Wagner C., and Mudd S.H. Glycine N-methyltransferase deficiency: a new patient with a novel mutation. J. Inherit. Metab. Dis. 26 (2003) 745-759
4. Barrier, L., Ingrand, S., Damjanac, M., Bilan, A.R., Hugon, J., Page, G. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease. Neurobiol. Aging, in press.
5. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
6. Bergmeyer H.U. Cholesterol and esterified cholesterol. Methods of enzymatic analysis. second ed. vol. 4 (1974), Verlag Chemie 1890-1893
7. Benevenga N.J., and Steele R.D. Adverse effects of excessive consumption of amino acids. Annu. Rev. Nutr. 4 (1984) 157-181
8. Bradford M.M. A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
9. Brusque A.M., Terracciano S.T., Fontella F.U., Vargas C., da Silva C.G., Wyse A.T.S., Trindade V.M.T., Wannmacher C.M.D., and Wajner M. Chronic administration of propionic acid reduces ganglioside N-acetylneuraminic acid concentration in cerebellum of young rats. J. Neurol. Sci. 158 (1998) 121-124
10. Chamberlin M.E., Ubagai T., Mudd S.H., Wilson W.G., Leonard J.V., and Chou J.Y. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J. Clin. Invest. 98 (1996) 1021-1027
11. 2+-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
12. Clark J.B., Bates T.E., Cullingford T., and Land J.M. Development of enzymes of energy metabolism in the neonatal mammalian brain. Dev. Neurosci. 15 (1993) 174-180
13. Davis H.P., and Squire L.R. Protein synthesis and memory: a review. Psychol. Bull. 96 (1984) 518-559
14. Dobbing J., and Sands J. Vulnerability of developing brain. IX. The effect of nutritional growth retardation on the timing of the brain growth-spurt. Biol. Neonate 19 (1971) 363-378
15. du Bois T.M., Deng C., and Huang X.-F. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 878-888
16. 2. Neurochem. Res. 29 (2004) 1961-1977
17. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
18. Garlick P.J. Toxicity of methionine in humans. J. Nutr. 136 (2006) 1722S-1725S
19. Izquierdo I., Izquierdo L.A., Barros D.M., Mello e Souza T., de Souza M.M., Quevedo J., Rodrigues C., Sant'Anna M.K., Madruga M., and Medina J.H. Differential involvement of cortical receptor mechanisms in working, short-term and long-term memory. Behav. Pharmacol. 9 (1998) 421-427
20. Jones D.H., and Matus A.I. Isolation of plasma synaptic membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta 356 (1974) 276-287
21. Kamboj A., Kiran R., and Sandhir R. N-acetylcysteine ameliorates carbofuran-induced alterations in lipid composition and activity of membrane bound enzymes. Mol. Cell. Biochem. 286 (2006) 104-114
22. Kolter T., Proia R.L., and Sandhoff K. Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277 (2002) 25859-25862
23. Lake B.D., and Goodwin H.J. Lipids. In: Smith I., and Seakings J.W.T. (Eds). Chromatographic and Eletrophoretic Techniques. Paper and Thin Layer Chromatography vol. 1 (1976), William Heinemann Medical Books Ltd, London 345-366
24. Lehotsky J., Kaplan P., Matejovicova M., Murin R., Racay P., and Raeymaekers L. Ion transport systems as targets of free radicals during ischemia reperfusion injury. Gen. Physiol. Biophys. 21 (2002) 31-37
25. Loo Y.H., Fulton T., Miller K., and Wisniewski H.M. Phenylacetate and brain dysfunction in experimental phenylketonuria: synaptic development. Life Sci. 27 (1980) 1283-1290
26. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
27. Mecocci P., Beal M.F., Cecchetti R., Polidori M.C., Cherubini A., Chionne F., Avellini L., Romano G., and Senin U. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol. 31 (1997) 53-64
28. Mocchetti I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell. Mol. Life Sci. 62 (2005) 2283-2294
29. Molander-Melin M., Blennow K., Bogdanovic N., Dellheden B., Mansson J.E., and Fredman P. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92 (2005) 171-182
30. Mudd S.H., Jenden D.J., Capdevila A., Roch M., Levy H.L., and Wagner C. Isolated hypermethioninemia: measurements of S-adenosylmethionine and choline. Metabolism 49 (2000) 1542-1547
31. Mudd S.H., Levy H.L., and Kraus J.P. Disorders of transsulfuration. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eighth ed. (2001), McGraw-Hill, New York 2007-2056
32. Nagai Y. Functional roles of gangliosides in bio-signaling. Behav. Brain Res. 66 (1995) 99-104
33. Nakamura K., and Handa S. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal. Biochem. 142 (1984) 406-410
34. Nores G.A., Mitzumari R.K., and Kremer D.M. Chromatographic tank designed to obtain highly reproducible high-performance thin-layer chromatograms of gangliosides and neutral glycosphingolipids. J. Chromatogr. 686 (1994) 155-157
35. Ohvo-Rekilä H., Ramstedt B., Leppimäki P., and Slotte J.P. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41 (2002) 66-97
36. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
37. Paratcha G., and Ibanez C.F. Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr. Opin. Neurobiol. 12 (2002) 542-549
38. Rahmann H. Brain gangliosides and memory formation. Behav. Brain Res. 66 (1995) 105-116
39. Ramirez M.R., Muraro F., Zylbersztejn D.S., Abel C.R., Arteni N.S., Lavinsky D., Netto C.A., and Trindade V.M.T. Neonatal hypoxia-ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus. Neurosci. Res. 46 (2003) 339-347
40. Regina M., Korhonen V.P., Smith T.K., Alakuijala L., and Eloranta T.O. Methionine toxicity in the rat in relation to hepatic accumulation of S-adenosylmethionine: prevention by dietary stimulation of the hepatic transsulfuration pathway. Arch. Biochem. Biophys. 300 (1993) 598-607
41. She J.-Q., Wang M., Zhu D.-M., Sun L.-G., and Ruan D.-Y. Effect of ganglioside on synaptic plasticity of hippocampus in lead-exposed rats in vivo. Brain Res. 1060 (2005) 162-169
42. Skoza L., and Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem. J. 159 (1976) 457-462
43. +-ATPase activity, lipid peroxidation and nonenzymatic antioxidant defenses in rat hippocampus. Int. J. Dev. Neurosci. 23 (2005) 651-656
44. Stefanello F.M., Matté C., Scherer E.B., Wannmacher C.M.D., Wajner M., and Wyse A.T.S. Chemically induced model of hypermethioninemia in rats. J. Neurosci. Methods 160 (2007) 1-4
45. +-ATPase activity in hippocampus of rats. Metab. Brain Dis. 22 (2007) 172-182
46. Streck E.L., Delwing D., Tagliari B., Matté C., Wannmacher C.M.D., Wajner M., and Wyse A.T.S. Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem. Int. 43 (2003) 597-602
47. +-ATPase activity by the metabolites accumulating in homocystinuria. Metab. Brain Dis. 17 (2002) 83-91
48. Suzuki T. Lipid rafts at postsynaptic sites: distribution, function and linkage to postsynaptic density. Neurosci. Res. 44 (2002) 1-9
49. Svennerholm L. Quantitative estimation of sialic acids a colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24 (1957) 604-611
50. Svennerholm L. Chromathographic separation of human brain gangliosides. J. Neurochem. 10 (1963) 613-623
51. Svennerholm L., Bostrom K., Jungbjer B., and Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 63 (1994) 1802-1811
52. Svennerholm L., and Gottfries C.-G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62 (1994) 1039-1047
53. Tettamanti G., and Riboni L. Ganglioside turnover and neural cell function: a new perspective. Prog. Brain Res. 101 (1994) 77-100
54. Trindade V.M.T., Brusque A.M., Raasch J.R., Pettenuzzo L.E., Rocha H.P., Wannmacher C.M.D., and Wajner M. Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids. Metab. Brain Dis. 17 (2002) 93-102
55. Trindade V.M.T., Daniotti J.L., Raimondi L., Chazan R., Netto C.A., and Maccioni H.J.F. Effects of neonatal hypoxia/ischemia on ganglioside expression in the rats hippocampus. Neurochem. Res. 26 (2001) 591-597
56. Valenza M., and Cattaneo E. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?. Prog. Neurobiol. 80 (2006) 165-176
57. Wajner M., Brites E.C., Dutra J.C., Buchalter M.S., Pons A.H., Pires R.F., Wannmacher L.E., Rosa Junior A., Trindade V.M.T., and Wannmacher C.M.D. Diminished concentrations of ganglioside N-acetylneuraminic acid (G-NeuAc) in cerebellum of young rats receiving chronic administration of methylmalonic acid. J. Neurol. Sci. 85 (1988) 233-238
58. +-ATPase, thick ascending limb. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R1328-R1337
59. +-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23 (1995) 261-263
60. +-ATPase activity after brain ischemia. Neurochem. Res. 25 (2000) 971-975